Abstract:Gut microbiota imbalance is one of the major causes of ulcerative colitis (UC). L. rhamnosus SHA113 (LRS), a strain isolated from healthy human milk, influences the regulation of gut flora. This study aims to determine whether this strain can ameliorate UC by modulating gut microbiota. Mouse models of UC were established using C57BL/6Cnc mice with intragastric administration of 3.0% (w/v) dextran sodium sulfate (DSS). LRS was used to treat the mouse models of UC with 109 cfu mL-1 cell suspension via intragastric administration. To verify the effect of gut microbiota on UC, fecal microbiota collected from the mice after the treatment with LRS were also used to treat the UC mouse models (FMT). The severity of UC was evaluated based on body weight, colon length, disease activity index (DAI), and hematoxylin-eosin staining. The microbial composition was analyzed by 16S rRNA sequencing. The mRNA expression levels of cytokines, mucins, tight junction proteins, and antimicrobial peptides in the gastrointestinal tract were detected by quantitative real-time polymerase chain reaction. The short-chain fatty acid (SCFAs) in the cecal contents of all mice were quantitatively detected by gas chromatography and mass spectrometry. Both LRS and FMT exerted excellent therapeutic effects on UC, as evidenced by the reduction in body weight loss, colon length, and colon structural integrity, as well as the increase in the DAI (disease activity index). LRS and FMT treatments showed similar effects: (1) an increase of total SCFA production in the cecal contents and the abundance of gut microbial diversity and flora composition; (2) decreases in two genera (Parabacteroides and Escherichia/Shigella) related to the DAI and the enhancement of SCFAs and IL-10 positively related genera in the gut microbiota (Bilophila, Roseburia, Akkermansia, and Bifidobacterium); (3) downregulation of the expression of tumor necrosis factor-α, interleukin IL-6, and IL-1β, and upregulation of the expression of the anti-inflammatory cytokine IL-10; and (4) upregulation of the expression of mucins (Muc1-4) and tight junction protein ZO-1. Overall, L. rhamnosus SHA113 relieves UC via the regulation of gut microbiota: increases in SCFA-producing genera and decreases in UC-related genera. In addition, a single strain is sufficient to induce a significant change in the gut microbiota and exert therapeutic effects on UC.

The Metabolites of Lactobacillus fermentum F-B9-1 Relieved Dextran Sulfate Sodium-Induced Experimental Ulcerative Colitis in Mice

Amelioration of Dextran Sulfate Sodium-Induced Experimental Ulcer Colitis in Mice by Bacillus licheniformis

Lactobacillus Fermentum CKCC1858 and Lactobacillus Plantarum CKCC1312 Ameliorate the Symptoms of Ulcerative Colitis in Mouse Model Induced by Dextran Sulfate Sodium

Gut microbiota modulation and anti-inflammatory properties of mixed lactobacilli in dextran sodium sulfate-induced colitis in mice

Effect of Lactobacillus with Feruloyl Esterase-Producing Ability on Dextran Sodium Sulfate-Induced Ulcerative Colitis in Mice

Lactobacillus fermentum ZS40 Ameliorates Inflammation in Mice With Ulcerative Colitis Induced by Dextran Sulfate Sodium

Effects of laminarin zwitterionic carboxylate and sulfonate on the intestinal barrier function and gut microbiota

Preventive effect of Lacticaseibacillus rhamnosus 2016SWU.05.0601 and its postbiotic elements on dextran sodium sulfate-induced colitis in mice

Beneficial Effects of Fecal Microbiota Transplantation on Ulcerative Colitis in Mice

The Role of a Novel Antibacterial Substance, Cyclic Opine-Producing Lacticaseibacillus Rhamnosus LS8 in Ameliorating Ulcerative Colitis: a Fecal Microbiota Transplantation Study

Determination of the effects of lactoferrin in a preclinical mouse model of experimental colitis.

Lactobacillus Plantarum 69-2 Combined with Α-Lactalbumin Hydrolysate Alleviates DSS-induced Ulcerative Colitis Through the TLR4/NF-κB Inflammatory Pathway and the Gut Microbiota in Mice.

Oral delivery of a Lactococcus lactis strain secreting bovine lactoferricin–lactoferrampin alleviates the development of acute colitis in mice

Protective Effect of Lactobacillus Fermentum CQPC04 on Dextran Sulfate Sodium-Induced Colitis in Mice is Associated with Modulation of the Nuclear Factor-Κb Signaling Pathway.

Lactobacillus plantarum 69-2 combined with α-lactalbumin hydrolysate alleviates DSS-induced ulcerative colitis by TLR4/NF-κB inflammatory pathway and gut microbiota in mice

Lactobacillus casei ATCC 393 and it's metabolites alleviate dextran sulphate sodium-induced ulcerative colitis in mice through the NLRP3-(Caspase-1)/IL-1β pathway

A Mixture of Lactobacillus fermentum HFY06 and Arabinoxylan Ameliorates Dextran Sulfate Sodium-Induced Acute Ulcerative Colitis in Mice

Mucosa-reparing and Microbiota-Balancing Therapeutic Effect of Bacillus Subtilis Alleviates Dextrate Sulfate Sodium-Induced Ulcerative Colitis in Mice.

Fecal Microbiota Transplantation (FMT) Alleviates Experimental Colitis in Mice by Gut Microbiota Regulation

Study of the alleviation effects of a combination of Lactobacillus rhamnosus and inulin on mice with colitis.

Lactobacillus Rhamnosus from Human Breast Milk Ameliorates Ulcerative Colitis in Mice Via Gut Microbiota Modulation.